No Data
Banks' "Wealth Management Night Market" trend is rising again, and the incremental scale of bank wealth management may reach 2-3 trillion yuan by 2025.
① Wealth management companies and Banks are actively creating and establishing "wealth management night markets," breaking time limitations to meet more investors' needs; ② Against the backdrop of declining deposit interest rates, bank wealth management still has vast development space. In the next step, wealth management companies can continue to strengthen efforts in product innovation, channel innovation, and service model innovation.
Leading mining company is making acquisitions! Zangge Mining is planning a change in control, and Zijin Mining Group intends to take the lead | Summary of the announcement.
Zangge Mining announced a significant notice, planning to transfer 24.72% of its shares, directly indicating a change of control, with the buyer being the mining giant Zijin Mining Group. It is worth noting that in recent years, Zangge Mining and Zijin Mining Group have made considerable moves in the expansion of lithium resources. The change of ownership of Zangge Mining to Zijin Mining Group is just one of several acquisition cases by the latter; looking at 2024 alone, Zijin Mining Group has already undertaken four large-scale acquisitions.
An alternative "going abroad" for centralized procurement of pharmaceuticals and medical devices? The China-ASEAN regional centralized procurement platform for pharmaceuticals has been launched, and the industry anticipates the birth of the first Order.
① Today, the China-ASEAN pharmaceutical regional procurement platform officially launched, with representatives from Shenzhen Mindray Bio-Medical Electronics, United Imaging Healthcare, SIMCERE PHARMA, and other companies present; ② Although the specific implementation plan is yet to be clarified, the industry believes it is undoubtedly Bullish for domestic pharmaceutical companies; ③ The Southeast Asian pharmaceutical market is growing rapidly, but it relies heavily on imported drugs and medical devices.
The transformation of the Banking Industry in adversity in 2024: the mud and dawn of the "light asset" vision.
How far is dawn?
Kweichow Moutai's 2024 performance has "initially submitted": annual growth exceeds 15%, and Moutai's base liquor has reduced production for the first time.
Response cycle.
Moutai liquor production cuts? Individuals close to Kweichow Moutai: last year's production remained within a normal and orderly Range | Quick read announcement.
In 2024, Kweichow Moutai plans to produce approximately 0.0563 million tons of Moutai liquor, a decrease of 1.58% year-on-year. Last year, increased marketing investments in the Moutai series of liquors and the higher proportion led to a decline in the company's overall net margin, which may have fallen below 50% last year, reaching the lowest level since 2018. Amid soft stock prices, Kweichow Moutai officially initiated a buyback, with nearly 0.3 billion yuan repurchased on the first day.